1. Home
  2. AGPU vs RANI Comparison

AGPU vs RANI Comparison

Compare AGPU & RANI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Axe Compute Inc. Common Stock

AGPU

Axe Compute Inc. Common Stock

BUY

Current Price

$7.87

Market Cap

83.5M

Sector

N/A

ML Signal

BUY

Logo Rani Therapeutics Holdings Inc.

RANI

Rani Therapeutics Holdings Inc.

BUY

Current Price

$0.61

Market Cap

84.6M

Sector

Health Care

ML Signal

BUY

Company Overview

Basic Information
Metric
AGPU
RANI
Founded
2002
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Medicinal Chemicals and Botanical Products
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
83.5M
84.6M
IPO Year
2008
2021

Fundamental Metrics

Financial Performance
Metric
AGPU
RANI
Price
$7.87
$0.61
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
★ $7.20
AVG Volume (30 Days)
281.5K
★ 527.3K
Earning Date
11-13-2026
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 57.14
EPS
N/A
★ N/A
Revenue
$125,284.00
★ $1,633,000.00
Revenue This Year
$48,110.47
$283.19
Revenue Next Year
$614.07
$5.99
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
★ 58.85
52 Week Low
$1.03
$0.57
52 Week High
$13.49
$2.63

Technical Indicators

Market Signals
Indicator
AGPU
RANI
Relative Strength Index (RSI) 34.74 31.61
Support Level $7.44 N/A
Resistance Level $9.30 $0.85
Average True Range (ATR) 0.91 0.05
MACD -0.35 -0.02
Stochastic Oscillator 6.96 12.79

Price Performance

Historical Comparison
AGPU
RANI

About AGPU Axe Compute Inc. Common Stock

Axe Compute Inc functions as an active infrastructure operator. The company intends to expand access to AI compute resources by utilizing the Aethir network, which provides scalable, cost-efficient cloud GPU services for AI, machine learning, gaming, and rendering applications. Through the use of Aethir's decentralized international infrastructure, the company aims to provide access to bare-metal GPUs at scale for both emerging and established organizations.

About RANI Rani Therapeutics Holdings Inc.

Rani Therapeutics Holdings Inc is a clinical-stage biotherapeutics company advancing technologies to enable the development of orally administered biologics to provide patients, physicians, and healthcare systems with a convenient alternative to painful injections. The company has developed the RaniPill capsule, which is designed to deliver a wide variety of drug substances, including antibodies, proteins, peptides, and oligonucleotides. RaniPill is a proprietary and patented platform technology, intended to replace subcutaneous or IV injection of biologics with oral dosing. The company is also engaged in developing RaniPill HC, which is intended to enable the delivery of drug payloads in liquid form with high bioavailability.

Share on Social Networks: